SCHEMBL18197849

SCHEMBL18197849

c1cnc2ccc(Cc3nnc4cccnn34)cc2c1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19338390 0.84 MET (0.63) MET
SCHEMBL14346083 0.83 MET (1.00) MET
SCHEMBL1163324 0.83 MET (1.00) MET
SCHEMBL12049148 0.83 MET (0.75) MET
SCHEMBL14346082 0.80 MET (1.00) MET
SCHEMBL2699456 0.80 MET (0.78) MET
SCHEMBL12049152 0.80 MET (0.71) MET
SCHEMBL3590807 0.79 MET (0.69) MET
SCHEMBL2494788 0.79 MET (0.76) MET
SCHEMBL12049044 0.79 MET (0.69) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966214-B9 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-13 EP disclosed
EP-1966214-B1 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-02 EP disclosed